AwardedCzechiaGoodsCZK 238,348,725
Dodávky LP CARVYKTI
- Published
- Published 10 July 2026
Overview
Fakultní nemocnice Ostrava has awarded a contract to Janssen-Cilag s.r.o. for ongoing and repeated supply of the pharmaceutical product LP Carvykti, a cytostatic agent for autologous cell immunotherapy based on T-lymphocytes. The contract value is 238,348,724.88 CZK, with deliveries to be made based on individual orders from the hospital pharmacy.
Key details
- Country
- Czechia
- Status
- Awarded
- Category
- Goods
- Estimated value
- CZK 238,348,725
- Procedure
- Direct
- Published
- 10 July 2026
Antineoplastic and immunomodulating agents
Award outcome
- Awarded value
- CZK 238,348,725
- Award date
- 1 July 2026
- Contract period
- 1 July 2026 → 20 June 2028
- Janssen-Cilag s.r.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
17 July 2026
Contract Award Notice
10 July 2026
Contracting authority
Fakultní nemocnice Ostrava
Procuring entityOstrava, Czechia
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.